Keysight FY26 Q3 net income more than doubles to $397 million; revenue rises 36% to $1.85 billion
Reuters2026/09/02 20:11Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!
A welcome pack worth 6200 USDT for new users! Sign up now!
- Keysight posted fiscal Q3 net income of USD 397 million, more than doubled from a year earlier as revenue climbed 36% to USD 1.85 billion.
- Operating income jumped 97% to USD 461 million, lifting operating margin by 8 percentage points to 24.9%.
- Orders rose 56% to USD 2.09 billion; revenue growth was led by CSG, up 43% to USD 1.35 billion.
- EISG revenue increased 21% to USD 501 million, supported by AI-driven demand for advanced semiconductor technologies and fabrication capacity.
- Management flagged a USD 100 million IEEPA tariff refund claims receivable, offset by a USD 40 million customer surcharge refund liability.
Disclaimer:
This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Keysight Technologies Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001601046-26-000036), on September 02, 2026, and is solely responsible for the information contained therein.
0
0
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now!
You may also like
ASP Isotopes COO Robert Ainscow sells 25,000 shares for $97,625
Reuters•2026/09/05 01:33
BioCardia CEO Peter Altman buys 800 shares for $872
Reuters•2026/09/05 01:31
Inturai Ventures closes final tranche of private placement, raises $22,714.05
Reuters•2026/09/05 01:27
With support from Ober and Bain Capital, RNA rising star Adarx submits US IPO application
Adarx Pharmaceuticals Inc. has filed for an IPO in the United States to help fund the development of a pipeline of drugs aimed at treating various diseases by regulating gene expression.
智通财经•2026/09/05 01:16

Crypto prices
MoreBitcoin
BTC
$79,603.58
-1.71%
Ethereum
ETH
$2,453.97
-2.05%
Tether USDt
USDT
$1
+0.00%
BNB
BNB
$723
+0.43%
XRP
XRP
$1.4
-2.94%
USDC
USDC
$0.9999
-0.01%
Solana
SOL
$101.98
-1.61%
TRON
TRX
$0.3319
+0.51%
Hyperliquid
HYPE
$84.07
-3.46%
Zcash
ZEC
$1,016.88
+8.31%
How to buy BTC
Bitget lists BTC – Buy or sell BTC quickly on Bitget!
Trade now
Become a trader now?A welcome pack worth 6200 USDT for new users!
Sign up now